AAAAAA

   
Results: 1-17 |
Results: 17
Organotins disrupt components of glutamate homeostasis in rat astrocyte cultures
Authors: Karpiak, VC Bridges, RJ Eyer, CL
Citation: Vc. Karpiak et al., Organotins disrupt components of glutamate homeostasis in rat astrocyte cultures, J TOX E H A, 63(4), 2001, pp. 273-287
Na+ transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437
Authors: Bridges, RJ Newton, BB Pilewski, JM Devor, DC Poll, CT Hall, RL
Citation: Rj. Bridges et al., Na+ transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437, AM J P-LUNG, 281(1), 2001, pp. L16-L23
Protease-activated receptor-2-mediated inhibition of ion transport in human bronchial epithelial cells
Authors: Danahay, H Withey, L Poll, CT Van De Graaf, SFJ Bridges, RJ
Citation: H. Danahay et al., Protease-activated receptor-2-mediated inhibition of ion transport in human bronchial epithelial cells, AM J P-CELL, 280(6), 2001, pp. C1455-C1464
Effect of cytochrome P450 1A induction on oxidative damage in rat brain
Authors: Liu, LP Bridges, RJ Eyer, CL
Citation: Lp. Liu et al., Effect of cytochrome P450 1A induction on oxidative damage in rat brain, MOL C BIOCH, 223(1-2), 2001, pp. 89-94
Benzimidazolone activators of chloride secretion: Potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease
Authors: Singh, S Syme, CA Singh, AK Devor, DC Bridges, RJ
Citation: S. Singh et al., Benzimidazolone activators of chloride secretion: Potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease, J PHARM EXP, 296(2), 2001, pp. 600-611
A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration
Authors: Maw, MA Corbeil, D Koch, J Hellwig, A Wilson-Wheeler, JC Bridges, RJ Kumaramanickavel, G John, S Nancarrow, D Roper, K Weigmann, A Huttner, WB Denton, MJ
Citation: Ma. Maw et al., A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration, HUM MOL GEN, 9(1), 2000, pp. 27-34
Pharmacological modulation of ion transport across wild-type and Delta F508 CFTR-expressing human bronchial epithelia
Authors: Devor, DC Bridges, RJ Pilewski, JM
Citation: Dc. Devor et al., Pharmacological modulation of ion transport across wild-type and Delta F508 CFTR-expressing human bronchial epithelia, AM J P-CELL, 279(2), 2000, pp. C461-C479
Familial idiopathic adulthood ductopenia: a report of five cases in three generations
Authors: Burak, KW Pearson, DC Swain, MG Kelly, J Urbanski, SJ Bridges, RJ
Citation: Kw. Burak et al., Familial idiopathic adulthood ductopenia: a report of five cases in three generations, J HEPATOL, 32(1), 2000, pp. 159-163
Estrogen inhibition of cystic fibrosis transmembrane conductance regulator-mediated chloride secretion
Authors: Singh, AK Schultz, BD Katzenellenbogen, JA Price, EM Bridges, RJ Bradbury, NA
Citation: Ak. Singh et al., Estrogen inhibition of cystic fibrosis transmembrane conductance regulator-mediated chloride secretion, J PHARM EXP, 295(1), 2000, pp. 195-204
Stimulation of Cl- secretion by chlorzoxazone
Authors: Singh, AK Devor, DC Gerlach, AC Gondor, M Pilewski, JM Bridges, RJ
Citation: Ak. Singh et al., Stimulation of Cl- secretion by chlorzoxazone, J PHARM EXP, 292(2), 2000, pp. 778-787
A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system
Authors: Bridges, RJ Kavanaugh, MP Chamberlin, AR
Citation: Rj. Bridges et al., A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system, CUR PHARM D, 5(5), 1999, pp. 363-379
Characterization of the internalization pathways for the cystic fibrosis transmembrane conductance regulator
Authors: Bradbury, NA Clark, JA Watkins, SC Widnell, CC Smith, HS Bridges, RJ
Citation: Na. Bradbury et al., Characterization of the internalization pathways for the cystic fibrosis transmembrane conductance regulator, AM J P-LUNG, 20(4), 1999, pp. L659-L668
Quinoline-2,4-dicarboxylic acids: Synthesis and evaluation as inhibitors of the glutamate vesicular transport system
Authors: Carrigan, CN Esslinger, CS Bartlett, RD Bridges, RJ Thompson, CM
Citation: Cn. Carrigan et al., Quinoline-2,4-dicarboxylic acids: Synthesis and evaluation as inhibitors of the glutamate vesicular transport system, BIOORG MED, 9(17), 1999, pp. 2607-2612
Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters
Authors: Koch, HP Kavanaugh, MP Esslinger, CS Zerangue, N Humphrey, JM Amara, SG Chamberlin, AR Bridges, RJ
Citation: Hp. Koch et al., Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters, MOLEC PHARM, 56(6), 1999, pp. 1095-1104
Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult
Authors: Koch, HP Chamberlin, AR Bridges, RJ
Citation: Hp. Koch et al., Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult, MOLEC PHARM, 55(6), 1999, pp. 1044-1048
Rescue of dysfunctional Delta F508-CFTR chloride channel activity by IBMX
Authors: Schultz, BD Frizzell, RA Bridges, RJ
Citation: Bd. Schultz et al., Rescue of dysfunctional Delta F508-CFTR chloride channel activity by IBMX, J MEMBR BIO, 170(1), 1999, pp. 51-66
Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells
Authors: Devor, DC Singh, AK Lambert, LC DeLuca, A Frizzell, RA Bridges, RJ
Citation: Dc. Devor et al., Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells, J GEN PHYSL, 113(5), 1999, pp. 743-760
Risultati: 1-17 |